STRS Ohio’s LB Pharmaceuticals LBRX Stock Holding History

STRS Ohio’s Portfolio LBRX Stock Details LBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,100	Closed	-$126K	–	2371
2026 Q1	$126K	Buy	5,100 +1,700	+50%	+$39.2K	﹤0.01%	1695
2025 Q4	$75.7K	Buy	+3,400	New	+$59.4K	﹤0.01%	1885

Other funds holding LBRX

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Trails Edge Capital Partners Atlanta, Georgia $630M AUM

JP Morgan Chase

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Spruce Street Capital New York $510M AUM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

STRS Ohio's LBRX Position: Q2 2026 in Review

STRS Ohio sold out of LB Pharmaceuticals (LBRX) in Q2 2026, closing a stake of 5,100 shares — an estimated $126K sold.

STRS Ohio first reported a position in LBRX in Q4 2025 and held it in 2 quarters. The position peaked at $126K in Q1 2026. 114 funds tracked by Wall St. Rank hold LBRX as of Q2 2026.

STRS Ohio reported no remaining LB Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
STRS Ohio sold 5,100 LB Pharmaceuticals shares in Q2 2026, an estimated $126K.
STRS Ohio first reported a position in LB Pharmaceuticals in Q4 2025 and held it in 2 quarters.
STRS Ohio's LB Pharmaceuticals position peaked at $126K in Q1 2026.
114 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.